NCT06638931 2026-04-15ANTARESInstituto do Cancer do Estado de São PauloPhase 2 Recruiting28 enrolled
NCT06299163 2025-07-23NM32-2668 in Adult Patients With Selected Advanced Solid TumorsNumab Therapeutics AGPhase 1 Terminated11 enrolled